IRIS - Res&Arch Institutional Research Information System - Research & Archive

BASILEO, Michela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.516
EU - Europa 1.069
AS - Asia 453
SA - Sud America 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.044
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.456
IE - Irlanda 324
UA - Ucraina 299
VN - Vietnam 165
HK - Hong Kong 164
IT - Italia 112
FI - Finlandia 82
DE - Germania 61
SE - Svezia 58
CA - Canada 56
RU - Federazione Russa 55
CN - Cina 53
TR - Turchia 37
BE - Belgio 21
GB - Regno Unito 15
KR - Corea 15
LB - Libano 12
CH - Svizzera 9
FR - Francia 9
PL - Polonia 6
AT - Austria 5
NL - Olanda 4
UZ - Uzbekistan 4
CZ - Repubblica Ceca 3
MX - Messico 3
GR - Grecia 2
PE - Perù 2
SG - Singapore 2
AR - Argentina 1
AU - Australia 1
ES - Italia 1
EU - Europa 1
GH - Ghana 1
GL - Groenlandia 1
IN - India 1
NO - Norvegia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.044
Salva come PNG Salva come JPEG
Città #
Chandler 397
Dublin 324
Jacksonville 166
San Mateo 166
Dong Ket 165
Hong Kong 164
Medford 71
Princeton 71
Ann Arbor 70
Ottawa 55
Andover 49
Beijing 45
Wilmington 42
Izmir 37
Perugia 22
Saint Petersburg 21
Altamura 16
Norwalk 15
Dongjak-gu 14
Genoa 13
Lawrence 13
Brussels 12
Des Moines 12
Falls Church 11
Helsinki 11
Boardman 10
Redwood City 9
Longueville 6
Houston 5
Redmond 5
New York 4
Bastia umbra 3
Belfiore 3
Den Haag 3
Heusden 3
Moscow 3
Padova 3
Pozzallo 3
Sona 3
Woodbridge 3
Yorktown 3
Amelia 2
Ashburn 2
Auburn Hills 2
Bologna 2
Cuernavaca 2
Faenza 2
Lima 2
Montenero di Bisaccia 2
Naples 2
Pistoia 2
San Paolo di Civitate 2
Santa Maria Imbaro 2
Singapore 2
Terni 2
Turin 2
Andra 1
Bratislava 1
Bucharest 1
Buenos Aires 1
Creazzo 1
Dearborn 1
Falkenstein 1
Figline Valdarno 1
Florence 1
Frankfurt Am Main 1
Hamilton 1
Lausanne 1
Lenzburg 1
Los Angeles 1
L’Aquila 1
Melbourne 1
Messina 1
Mexico City 1
Milan 1
Muenster 1
Nanchang 1
Napoli 1
Nuuk 1
Oslo 1
Pescara 1
San Diego 1
Seattle 1
Seoul 1
Shanghai 1
Springfield 1
Stockholm 1
Tempio Pausania 1
Warsaw 1
Totale 2.114
Salva come PNG Salva come JPEG
Nome #
Diagnosi molecolare di sepsi: impiego della PCR Real-Time 88
Antibody response and protection after intradermal and intramuscular 2011/2012 trivalent influenza vaccination in elderly volunteers 83
Molecular analysis of Group of Rotaviruses detected in subjects with severe acute gastroenteritis in Umbria from 2006 to 2012 74
Antibody Responses after Influenza Vaccination in Elderly People: Useful Information from a 27-Year Study (from 1988–1989 to 2014–2015) 70
Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study. 67
Annually repeated influenza vaccination and humoral response in elderly volunteers. 65
Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase. 64
Critical appraisal of five international guidelines on fresh frozen plasma clinical use. 64
An influenza A/H3 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home. 62
Audit clinico sull’impiego di plasma fresco congelato (PFC) in Umbria: disegno dello studio e risultati preliminari. 62
Influenza vaccination in patients on long-term anticoagulant therapy. 60
An influenza A/H3 outbreak during the 2004/2005 winter in elderlyvaccinated people living in a nursing home 58
Influenza vaccine immunogenicity and efficacy in istitutionalized elderly volunteers (winter season 2002/03). 57
Audit of the clinical use of fresh-frozen plasma in umbria: study design and results. 57
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age. 56
Antibody response against unchanged influenza vaccine components in elderly people vaccinated in consecutive years 55
Induzione di risposta immunitaria e di protezione da parte dei vaccini antinfluenzali in soggetti anziani. 53
Influenza vaccination in patients on long-term anticoagulant therapy 53
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 52
Differente risposta anticorpale al vaccine anti-influenzale per l’inverno 2008/2009 in soggetti anziani residenti in due differenti case di riposo. 52
An observational retrospective study provide information on hospitalization and severe outcomes of the 2009 A(H1N1) infection in Italy. 51
Influenza vaccine induced antibody response against B influenza viruses included in the vaccine or naturally circulating during the winter season 2010/2011 50
Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulatingA(H3N2)strains 50
Antibody response elicited by 2012/2013 “implemented influenza vaccines”, FLUAD® (Novartis Vaccines & Diagnostics) and INTANZA® 15Mcg (Sanofi Pasteur MSD), in chronically ill institutionalized elderly volunteers 48
The good use of plasma. A critical analysis of five international guidelines. 47
Computer assisted vka monitoring with point of care device by general practitioners. 46
Prospective assessment of clinical endpoints of vka treatment in a primary care computer assisted management model. 46
Induction of cross-reactive antibodies to 2009 pandemic H1N1 influenza virus (pH1N1) after seasonal vaccination (winters 2003/04 and 2007/08). 46
Immunogenicity of conventional trivalent inactivated influenza vaccines in pre-vaccination unprotected elderly volunteers in five winters seasons. 45
Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. 45
Clinical audit of the use of fresh frozen plasma in Umbria: study design and results of the pilot phase. 44
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. 43
Induction of Cross-Reactive Antibodies to 2009 Pandemic H1N1 Influenza Virus (pH1N1) After Seasonal Vaccination (Winters 2003/04 and 2007/08) 43
Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. 43
MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and enderly volunteers (winter season 2003/04). 42
The intersubunit region of influenza virus haemagglutinin as a peptide vaccine candidate. 42
Preliminary survey of human intestinal parasitosis in a Peruvian Andean zone 41
Immunogenicity of the MF-59-adjuvanted vaccine in volunteers of different group of age. 41
Comparative study on immunogenicity among split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 41
Clinical characteristics of influenza A/H1N1, A/H3N2 and B infections in children during three consecutive winter seasons (2012-13, 2013-14 and 2014-15) 41
Partial Protection Induced by 2011–2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People 41
COMPUTER ASSISTED VKA MONITORING WITH POINT OF CARE DEVICE BY GENERAL PRACTITIONERS. 40
Hospitalization associated with 2009 pandemic influenza A(H1N1) infection in Umbria, a region of central Italy, July – December 2009. 39
Pro-inflammatory cytokines/ chemokines production after infection of A549 Human epithelial cell line with different strains of human influenza viruses 39
CLINICAL AUDIT OF THE USE OF FRESH FROZEN PLASMA IN UMBRIA. 39
Fresh Frozen Plasma Transfusion Practice: A Regional Benchmark Study. 38
Seroprevalence against pandemic influenza A(H1N1) 2009 after the first season of circulation in Italy 37
Influenza vaccine induction of cross–reactive antibodies against different B/Yamagata and B/Victoria-like influenza viruses. , 36
Inhibitor development in mild/moderate haemophilia: could influenza vaccination have been the trigger? 36
VALUTAZIONE DELL’EFFICACIA PROTETTIVA E DELLA CAPACITA’ DI INDURRE ANTICORPI CROSS-REATTIVI NEI CONFRONTI DI VIRUS INFLUENZALI DI TIPO B APPARTENENTI AI LINEAGGI YAMAGATA E VICTORIA DA PARTE DI DUE VACCINI INFLUENZALI TRIVALENTI (FLUAD® E INTANZA®) IN ANZIANI ISTITUZIONALIZZATI 36
Comparison of the BD Phoenix system with the cefoxitin disk diffusion test for detection of methicillin resistance in Staphylococcus aureus and coagulase-negative staphylococci. 36
Utilizzo di AGREE per l’analisi delle linee guida (LG) internazionali sul buon uso del plasma. 36
Comparative study of immunogenicity of split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 35
AUDIT OF THE CLINICAL USE OF FRESH-FROZEN PLASMA IN UMBRIA: STUDY DESIGN AND RESULTS. 34
Sorveglianza delle paralisi flaccide acute nella regione Umbria 33
Seroprevalence to the 2009 pandemic influenza a(H1N1) virus in the italian population after the 2009 pandemic (September/November 2010) 32
Soggetti ricoverati in ospedale in Umbria con diagnosi di laboratorio di infezione da virus influenzale pandemico A/H1N1 nel periodo Luglio 2009 - Marzo 2010 32
INTERNATIONAL GUIDELINES ABOUT CLINICAL USE OF FRESH FROZEN PLASMA: A CRITICAL APPRAISAL. 32
INHIBITOR DEVELOPMENT IN MILD HAEMOPHILIA A: COULD INFLUENZA VACCINATION HAVE BEEN THE TRIGGER? 32
Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review 32
Laboratory confirmed pandemic H1N1 influenza virus infections in hospitalization in Umbria, a region of central Italy (May-November 2009). 31
Intradermal and intramuscular 2011-2012 influenza vaccination of elderly institutionalized volunteers: induction of antibody responses against vaccine and epidemic influenza virus strains 31
Sondaggio conoscitivo coproparassitologico in una zona andina della Cordillera Blanca, Peru'. 30
The new pandemic A/H1N1 influenza virus (pH1N1): celluler and humoral cross-reactive immune responses induced in healthy adults following 2007/2008 influenza vaccination. 29
The good use of plasma. A critical analysis of five international guidelines. 29
Il processo di validazione clinica di un algoritmo computerizzato per il monitoraggio della TAO 28
Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus 27
Sorveglianza molecolare delle gastroenteriti da rotavirus in Umbria 24
ENDOGENOUS INTERLEUKYN-6 LEVELS AND ANTIBODY RESPONSE TO INACTIVATED INFLUENZA VACCINE IN PLURIVACCINATED ELDERLY VOLUNTEERS 22
PROSPECTIVE ASSESSMENT OF CLINICAL ENDPOINTS OF VKA TREATMENT IN A PRIMARY CARE COMPUTER ASSISTED MANAGEMENT MODEL 18
Serological evidence of partial protection against infection with A/H3N2 circulating drifted strains after immunization with enhanced 2011/2012 trivalent influenza vaccines 15
Totale 3.146
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.732
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201945 0 0 0 0 0 0 0 0 0 4 41 0
2019/2020310 3 4 42 4 41 0 44 59 51 42 9 11
2020/2021664 14 51 6 56 183 14 56 4 50 11 50 169
2021/2022512 5 101 1 12 22 8 6 213 6 10 57 71
2022/20231.072 75 102 9 102 106 111 0 63 442 5 36 21
2023/2024315 28 42 28 9 3 0 141 20 39 5 0 0
Totale 3.146